News

usePAT GmbH receives fresh capital for internationalization

The usePAT GmbH, a young high-tech company from Vienna, is a provider of accurate measuring solutions. With the patented…

TU Wien: Kräftiger Schub für Österreichs Arzneimittelforschung

Technologietransfer-Fonds KHAN-I und w4i schließen Rahmenvereinbarung mit 19 österreichischen Forschungseinrichtungen –…

APEPTICO and the Solnatide H2020 team participated in the ePitching to procurers on COVID-19 initiated by the European Innovation Council

The Solnatide COVID-19 treatment project is the only project „made in Austria“ selected and supported by the European…

CeMM: Drug discovery: First highly scalable method developed to monitor protein levels and localizations in cells

Until now, scientists typically studied the changes of proteins and their roles in the cell by using a fluorescent tag…

MedUni Vienna: Identification of new factor that offers potential new therapeutic strategy for obesity

Obesity is a serious global health problem and a risk factor for diseases such as type II diabetes, heart disease and…

Neue Führung im FOPI

Präsident Ingo Raimon und Thomas Haslinger übergeben an VizepräsidentInnen und neues Generalsekretariat

Technology transfer fund KHAN-I and w4i conclude framework agreement with 19 Austrian research institutes

Three Austrian projects are already being financed by KHAN-I. Framework conditions for close and efficient cooperation…

Boehringer Ingelheim beginnt klinische Phase-2-Studie

Studie untersucht zielgerichtete Therapie für Patienten mit schweren Atemwegskomplikationen aufgrund von COVID-19

Boehringer: Weltdiabetestag: COVID-19 und Herz-Kreislauferkrankungen sind wenig beachtete Gefahren bei Diabetes

- Diabetes auf dem Vormarsch: 463 Mio. Erwachsene leiden an Typ-2-Diabetes (1)

- Herz-Kreislauf-Erkrankungen eine der…

FOPI Grünbuch „COVID-19 and beyond“: Wegweisende Überlegungen

Was können wir aus der COVID-19-Krise lernen? Wo gibt es Ansatzpunkte für Verbesserungen? Und was wollen wir…

Symptoma: 1,5 Millionen Aufrufe in 24 Stunden: Stadt Wien verzeichnet Ansturm auf neuen Corona-Chatbot

Integration des Symptoma Chatbots kommt nicht nur bei den Wiener Bürgern gut an:…

Lexogen has developed the first commercial Covid-19 ultra-high-throughput test for true public health mass screening

Lexogen GmbH, a Vienna-based market leader in Next-Generation Sequencing (NGS) and transcriptomics announced today the…

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.